The Ministry makes Official Information Act (OIA) responses available where the information is considered to be of public interest, and where there is no risk to the privacy of individuals. The names and contact details of requestors are removed before publication.
To find out more about making an OIA request, visit OIA requests, where you can make a request via the online tool. Alternatively you can email the OIA Services team.
Documents are usually available in Adobe PDF format only.
| Publication date | Response date | Details of the request | Download |
|---|---|---|---|
| 27 June 2024 | 14 June 2024 | Use of Remdesivir |
H2024042455 Response (pdf, 369 KB) H2024042455 Documents - 1 (pdf, 9.8 MB) H2024042455 Documents - 2 (pdf, 9.8 MB) H2024042455 Documents - 3 (pdf, 10 MB) H2024042455 Documents - 4 (pdf, 9.9 MB) H2024042455 Documents - 5 (pdf, 4.2 MB) |
| 27 June 2024 | 01 June 2024 | Adverse reactions to medicines |
H2024040708 Response (pdf, 222 KB) H2024036455 Response (pdf, 302 KB) |
| 27 June 2024 | 01 June 2024 | Assault in aged care facilities | H2024039943 Response (pdf, 148 KB) |
| 27 June 2024 | 01 June 2024 | COVID-19 vaccination data | H2024040466 Response (pdf, 433 KB) |
| 27 June 2024 | 01 June 2024 | Early Medical Abortion (EMA) medication | H2024041333 Response (pdf, 180 KB) |
| 27 June 2024 | 01 June 2024 | H5N1 | H2024041379 Response (pdf, 280 KB) |
| 27 June 2024 | 01 June 2024 | Importation of surgical mesh products | H2024030123 Response (pdf, 224 KB) |
| 27 June 2024 | 01 June 2024 | Late term abortion data (from 2021) | H2024041811 Response (pdf, 166 KB) |
| 27 June 2024 | 01 June 2024 | Medicinal cannabis product export | H2024041365 Response (pdf, 172 KB) |
| 27 June 2024 | 01 June 2024 | Medicinal Cannabis Scheme | H2024039976 Response (pdf, 189 KB) |
| 27 June 2024 | 01 June 2024 | National Immunisation Technical Advisory Group (NITAG) | H2024040471 Response (pdf, 3 MB) |
| 27 June 2024 | 01 June 2024 | Nuvaxovid | H2024040015 Response (pdf, 115 KB) |
| 27 June 2024 | 01 June 2024 | Section 31 of the Health and Disability Services (Safety) Act 2001. | H2024040506 Response (pdf, 141 KB) |
| 27 June 2024 | 01 June 2024 | Section 34A(4) of the Medicines Act 1981 | H2024039979 Response (pdf, 3.4 MB) |
| 27 June 2024 | 01 June 2024 | Workplace culture reviews | H2024040728 Response (pdf, 190 KB) |
| 27 June 2024 | 31 May 2024 | Cost for implementing fluoridation | H2024042074 Response (pdf, 272 KB) |
| 27 June 2024 | 31 May 2024 | COVID-19 vaccines and reinfection | H2024041128 Response (pdf, 314 KB) |
| 27 June 2024 | 31 May 2024 | Medical abortions | H2024041806 Response (pdf, 225 KB) |
| 27 June 2024 | 25 April 2024 | New Zealand Health Survey | H2024038608 Response (pdf, 270 KB) |
| 27 June 2024 | 25 April 2024 | Smokefree Environments and Regulated Products Amendment Bill | H2024036892 Response (pdf, 203 KB) |
| 27 June 2024 | 20 April 2024 | Natural Health Products | H2024039347 Response (pdf, 167 KB) |
| 27 June 2024 | 19 April 2024 | Employment policies | H2024037848 Response (pdf, 918 KB) |
| 27 June 2024 | 18 April 2024 | Childhood obesity | H2024039332 Response (pdf, 193 KB) |
| 27 June 2024 | 18 April 2024 | Long COVID Expert Advisory Group | H2024038582 Response (pdf, 219 KB) |
| 27 June 2024 | 18 April 2024 | National Reserve Supply | H2024038704 Response (pdf, 1.3 MB) |
| 27 June 2024 | 18 April 2024 | Vaping Product Retailers | H2024037791 Response (pdf, 312 KB) |
| 27 June 2024 | 17 April 2024 | Sale of vaping products | H2024039174 Response (pdf, 270 KB) |
| 27 June 2024 | 03 April 2024 | COVID-19 Public Health Response (Protection Framework) Order 2021 | H2024038239 Response (pdf, 268 KB) |
| 27 June 2024 | 22 March 2024 | Vaping Regulatory Authority | H2023031965 Response (pdf, 365 KB) |
| 26 June 2024 | 25 June 2024 | Gumboot Friday | H2024042547 Response (pdf, 231 KB) |
| 26 June 2024 | 24 June 2024 | Funding provided to the health and Disabilities Commissioner (2018/19 - 2022/23) | H2024043241 Response (pdf, 433 KB) |
| 26 June 2024 | 21 June 2024 | Māori Primary Health Care | H2024042077 Response (pdf, 1.7 MB) |
| 26 June 2024 | 21 June 2024 | Palliative care services and assisted dying | H2024044073 Response (pdf, 153 KB) |
| 26 June 2024 | 17 June 2024 | Adverse event reports (2021-2023) | H2024041985 Response (pdf, 346 KB) |
| 26 June 2024 | 13 June 2024 | Vaxzevria | H2024041698 Response (pdf, 289 KB) |
| 26 June 2024 | 10 June 2024 | Essure recall notice | H2024039036 Response (pdf, 6.4 MB) |
| 26 June 2024 | 07 June 2024 | COVID-19 hospitalisation and vaccine effectiveness | H2024041514 Response (pdf, 324 KB) |
| 26 June 2024 | 07 June 2024 | End of Life Choice Act 2019 | H2024041217 Response (pdf, 2.9 MB) |
| 26 June 2024 | 06 June 2024 | Long COVID | H2024041125 Response (pdf, 186 KB) |
| 26 June 2024 | 05 June 2024 | AstraZeneca COVID-19 vaccine | H2024041115 Response (pdf, 216 KB) |
| 26 June 2024 | 05 June 2024 | Dietary Supplements Regulations 1985 | H2024041709 Response (pdf, 288 KB) |
| 24 June 2024 | 21 June 2024 | Expenditure on consultants for the Ministry's restructuring and redundancy process | H2024040969 Response (pdf, 334 KB) |
| 12 June 2024 | 16 December 2023 | COVID-19 advice |
H202114740 Response (pdf, 1.9 MB) H202116279 Response (pdf, 2.2 MB) H2022013610 Response (pdf, 7.3 MB) |
| 05 June 2024 | 22 May 2024 | Expenditure on consultants and contractors (2017/18 - 2023/24 financial year) | H2024040175 Response (pdf, 2.5 MB) |
| 30 May 2024 | 30 May 2024 | Certification and surveillance audits | H2024041977 (pdf, 238 KB) |
| 28 May 2024 | 27 May 2024 | Appointment of Pharmac Chairperson | H2024040456 Response (pdf, 4.2 MB) |
| 23 May 2024 | 22 May 2024 | Assessment and certification of Aged Care Facilities | H2024040623 Response (pdf, 1.2 MB) |
| 15 May 2024 | 07 July 2023 | Prescription co-payments on subsidised medicines (1991 - 2008) | H2023027190 Response (pdf, 623 KB) |
| 09 May 2024 | 09 May 2024 | Manatū Hauora staffing | H2024039370 Response (pdf, 457 KB) |
| 08 May 2024 | 07 May 2024 | Manatū Hauora organisational change proposal | H2024039399 Response (pdf, 3.5 MB) |
| 06 May 2024 | 06 May 2024 | Long COVID statistics | H2024040314 Response (pdf, 215 KB) |
| 06 May 2024 | 29 April 2024 | Changes to the Suicide Prevention Office |
H2024039070 Response (pdf, 228 KB) H2024039043 Response (pdf, 234 KB) |
| 21 March 2024 | 15 March 2024 | Covid-19 expenditure from 2020-2022 | H2024036897 Response (pdf, 448 KB) |
| 15 March 2024 | 14 March 2024 | Number of medicinal cannabis packs sold monthly (November - December 2023) | H2024036434 Response (pdf, 769 KB) |
| 23 February 2024 | 23 February 2024 | Fluoridation of drinking water | H2024035465 Response (pdf, 272 KB) |
| 23 February 2024 | 22 February 2024 | Ministry of Health staff and COVID-19 leave | H2024035250 Response (pdf, 204 KB) |
| 23 February 2024 | 13 February 2024 | World Health Organisation and COVID-19 Vaccines | H2024034730 Response (pdf, 337 KB) |
| 22 February 2024 | 14 February 2024 | Information regarding drinking water regulations | H2024035795 Response (pdf, 2.8 MB) |
| 13 February 2024 | 12 February 2024 | Information on COVID-19 vaccines and reinfection | H2023034647 Response (pdf, 276 KB) |
| 13 February 2024 | 23 November 2023 | Burial and Cremation Act 1964 Medical Referees | H2023032283 Response (pdf, 8.6 MB) |
| 08 February 2024 | 11 April 2024 | New Zealand representation and engagement in processes to amend the International Health Regulations (2005) | H2023021072 Response (pdf, 251 KB) |
| 05 February 2024 | 02 February 2024 | Reporting of COVID-19 vaccination adverse events | H2024034984 Response (pdf, 202 KB) |
| 25 January 2024 | 17 October 2023 | Medsafe funding |
H2023032367 Response (pdf, 772 KB) H2023033150 Response (pdf, 144 KB) H2023031758 (pdf, 194 KB) |
| 24 January 2024 | 23 January 2024 | Information on the World Health Organisation International Health Regulation Amendments | H2023033366 Response (pdf, 5.4 MB) |
| 18 January 2024 | 17 January 2024 | Approved tobacco retailers in Northland | H2023033269 Response (pdf, 335 KB) |
| 18 January 2024 | 17 January 2024 | Data on adverse events following COVID-19 vaccination | H2023034156 Response (pdf, 276 KB) |
| 18 January 2024 | 17 January 2024 | Manatū Hauora - Ministry of Health branding | H2023033223 Response (pdf, 942 KB) |
| 18 January 2024 | 17 January 2024 | Ministry of Health legislative and operative framework | H2023033270 Response (pdf, 131 KB) |
| 18 January 2024 | 17 January 2024 | Number of medicinal cannabis packs sold monthly (September - October 2023) | H2023033580 Response (pdf, 685 KB) |
| 12 January 2024 | 19 December 2023 | Adverse events following immunisation for COVID-19 vaccines reported to Medsafe | H2023033190 Response (pdf, 150 KB) |
| 12 January 2024 | 12 December 2023 | Information regarding the COVID-19 Vaccine Technical Advisory Group and Long Covid |
H2023032995 Response 1 (pdf, 4.2 MB) H2023032995 Response 2 (pdf, 6.6 MB) |
| 12 January 2024 | 07 November 2023 | COVID-19 Vaccine and DNA contamination | H2023031858 Response (pdf, 172 KB) |
| 12 January 2024 | 24 May 2023 | Information regarding the pharmacy ownership model and the Therapeutic Products Bill | H2023023391 Response (pdf, 7.6 MB) |